'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitors.

Article Details


Handler N, Brunhofer G, Studenik C, Leisser K, Jaeger W, Parth S, Erker T

'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitors.

Bioorg Med Chem. 2007 Sep 15;15(18):6109-18. Epub 2007 Jun 20.

PubMed ID
17604631 [ View in PubMed

Resveratrol ((E)-3,4',5-trihydroxy-stilbene), a phytoalexin found in various plants, shows non-selective cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibition. In order to find more selective COX inhibitors a series of bridged stilbene derivatives was synthesized and evaluated for their ability to inhibit both COX-1 and COX-2 in vitro. The compounds showed a high rate of COX-1 inhibition with the most potent compounds exhibiting submicromolar IC(50) values and high selectivity indices. A prediction model for COX-inhibiting activity was also developed using the classical LIE approach resulting in consistent docking data for our molecule sample. Phenyl substituted 1,2-dihydronaphthalene derivatives and 1H-indene derivatives therefore represent a novel class of highly selective COX-1 inhibitors and land promising candidates for in vivo studies.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
Acetylsalicylic acidProstaglandin G/H synthase 2IC 50 (nM)100000N/AN/ADetails
CelecoxibProstaglandin G/H synthase 2IC 50 (nM)35N/AN/ADetails
ResveratrolProstaglandin G/H synthase 2IC 50 (nM)996N/AN/ADetails